MyRareDiet A Novel Diet Tracking Tool
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age1-80
SponsorOregon Health and Science University
About this trial
The investigators propose to develop and validate MyRareDiet® (MRD) to address an unmet need in the inborn errors of metabolism (IEM) population to assist with dietary management designed to increase adherence and compliance to treatment guidelines, while facilitating the collection of dietary data from individuals with IEM for research purposes.
Eligibility criteria
Qualifiers
diagnosed with urea cycle disorder, propionic acidemia, maple syrup urine disease or methylmalonic acidemia
consuming a diet where ≥50% of energy is supplied by foods consumed orally
self-known (or prescribed) dietary energy goal and protein restriction
internet connected device to access MyRareDiet
Disqualifiers
pregnant
Trial design
Treatments tested in this trial
- MDR diet assessment
- 24 hour recall
Treatment groups
60 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Oregon Health and Science University
Lead sponsor
BrightOutcome
Collaborator
National Urea Cycle Disorder Foundation
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator
Source ClinicalTrials.gov